110 ALLEN ROAD, BASKING RIDGE, NJ
Lisata Therapeutics Enters Amendment to Merger Agreement with Kuva Labs
Other Events
Waiver to Agreement and Plan of Merger
Ex-99.1
Lisata Therapeutics Enters Agreement for Acquisition by Kuva Labs
Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Investor Presentation
Q1
Amended Annual Report
FY 2025
Q3
Q2
FY 2024
Tender Offer Statement by Issuer
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload